p15PAF is overexpressed in multiple types of human cancer, including hepatocellular carcinoma [2], lung cancer [3], breast cancer [4], and pancreatic cancer [5], and its overexpression is associated with poor patient outcome [2]–[4]. Here, PCLAF is linked to cancer.